Cargando…
Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2
Oral cancers constitute approximately 2% of all cancers, with the most common histological type being oral squamous cell carcinoma (OSCC), representing 90% of oral cancers. Although diagnostic technologies and therapeutic techniques have progressed, the survival rate of patients with OSCC is still 6...
Autores principales: | Itai, Shunsuke, Yamada, Shinji, Kaneko, Mika K., Sano, Masato, Nakamura, Takuro, Yanaka, Miyuki, Handa, Saori, Hisamatsu, Kayo, Nakamura, Yoshimi, Furusawa, Yoshikazu, Fukui, Masato, Ohishi, Tomokazu, Kawada, Manabu, Harada, Hiroyuki, Kato, Yukinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086321/ https://www.ncbi.nlm.nih.gov/pubmed/30105309 http://dx.doi.org/10.1016/j.bbrep.2018.07.008 |
Ejemplares similares
-
Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome X-linked monoclonal antibody AMab-6
por: Kaneko, Mika K., et al.
Publicado: (2018) -
PMab-219: A monoclonal antibody for the immunohistochemical analysis of horse podoplanin
por: Furusawa, Yoshikazu, et al.
Publicado: (2019) -
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
por: Itai, Shunsuke, et al.
Publicado: (2018) -
Antibody–Drug Conjugates Using Mouse–Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model
por: Kato, Yukinari, et al.
Publicado: (2020) -
PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry
por: Ogasawara, Satoshi, et al.
Publicado: (2017)